Labeler
Cosette Pharmaceuticals, Inc. NDC Codes
Cosette Pharmaceuticals, Inc. lists 95 finished drug products in the FDA NDC Directory under NDC labeler code 0713.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Benicar HCT, Benicar, Triamcinolone Acetonide, Tribenzor, Tazarotene, Metronidazole, Azor, Fluocinolone Acetonide, Promethegan, Ambien, Ambien CR, Fluocinonide, Effient, Hydrocortisone Valerate, Betamethasone Dipropionate
- Active ingredients
- Olmesartan medoxomil, Hydrochlorothiazide, Amlodipine besylate, Triamcinolone acetonide, Promethazine hydrochloride, Tazarotene, Zolpidem tartrate, Metronidazole, Betamethasone dipropionate, Fluocinolone acetonide, Hydrocortisone, Calcipotriene
- NDC labeler codes
- 0713
- Strengths
- Olmesartan medoxomil 40 mg/1; Olmesartan medoxomil 20 mg/1; Hydrochlorothiazide 12.5 mg/1; Amlodipine besylate 5 mg/1; Hydrochlorothiazide 25 mg/1; Amlodipine besylate 10 mg/1; Metronidazole 7.5 mg/g; Triamcinolone acetonide 1 mg/g; Promethazine hydrochloride 6.25 mg/5mL; Hydrocortisone 10 mg/mL; Olmesartan medoxomil 5 mg/1; Tazarotene .5 mg/g; Betamethasone dipropionate .5 mg/g; Cevimeline hydrochloride 30 mg/1; Fluocinonide .5 mg/g; Tazarotene 1 mg/g; Hydrocortisone valerate 2 mg/g; Fluocinolone acetonide .25 mg/g; Nystatin 100000 [USP'U]/g; Gentamicin sulfate 1 mg/g
- Dosage forms
- Tablet, Film coated, Cream, Ointment, Suppository, Gel, Solution, Tablet, Coated, Suspension, Injection, Capsule, Lotion, Suspension/ drops, Shampoo, Suspension, Kit, Powder, For solution, Tablet, Paste
- Routes
- Topical, Oral, Rectal, Auricular (Otic), Vaginal, Subcutaneous, Intramuscular, Intravenous, Dental
- Drug classes (FDA established)
- Corticosteroid, Angiotensin 2 Receptor Blocker, Thiazide Diuretic, Calcium Channel Blocker, Dihydropyridine Calcium Channel Blocker, Phenothiazine, Retinoid, gamma-Aminobutyric Acid A Receptor Positive Modulator, Nitroimidazole Antimicrobial, Aminoglycoside Antibacterial, Azole Antifungal, Vitamin D Analog, Cholinergic Receptor Agonist, P2Y12 Platelet Inhibitor, Polyene Antifungal, Polymyxin-class Antibacterial, Opioid Agonist, Fluoroquinolone Antibacterial, Melanocortin Receptor Agonist, Sigma-1 Agonist, Uncompetitive N-methyl-D-aspartate Receptor Antagonist, Aluminum Complex, Nitrate Vasodilator, Sulfone, Methylating Agent, Tubulin Inhibiting Agent, Estrogen Agonist/Antagonist, Central Nervous System Stimulant, Ergotamine Derivative, Methylxanthine
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 148
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Benicar HCTolmesartan medoxomil-hydrochlorothiazide | Olmesartan medoxomil 20 mg/1; Hydrochlorothiazide 12.5 mg/1 | Tablet, Film coatedOral | 0713-0943 | 00713-0943-30 | — |
| Benicar HCTolmesartan medoxomil-hydrochlorothiazide | Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 25 mg/1 | Tablet, Film coatedOral | 0713-0945 | 00713-0945-30 | — |
| Benicar HCTolmesartan medoxomil-hydrochlorothiazide | Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 12.5 mg/1 | Tablet, Film coatedOral | 0713-0944 | 00713-0944-30 | — |
| Promethazine Hydrochloride and Codeine Phosphate | Promethazine hydrochloride 6.25 mg/5mL; Codeine phosphate 10 mg/5mL | SolutionOral | 0713-0823 | 00713-0823-75 | — |
| ciprofloxacin hydrochloride and hydrocortisone | Ciprofloxacin hydrochloride 2 mg/mL; Hydrocortisone 10 mg/mL | Suspension/ dropsAuricular (Otic) | 0713-0851 | 00713-0851-09 | — |
| Vyleesibremelanotide | Bremelanotide acetate 1.75 mg/.3mL | InjectionSubcutaneous | 0713-0897 | 00713-0897-04 | — |
| Promethazine Hydrochloride and Dextromethorphan Hydrobromide | Promethazine hydrochloride 6.25 mg/5mL; Dextromethorphan hydrobromide 15 mg/5mL | SolutionOral | 0713-0780 | 00713-0780-75 | — |
| Benicarolmesartan medoxomil | Olmesartan medoxomil 5 mg/1 | Tablet, Film coatedOral | 0713-0940 | 00713-0940-30 | — |
| Benicarolmesartan medoxomil | Olmesartan medoxomil 20 mg/1 | Tablet, Film coatedOral | 0713-0941 | 00713-0941-30 | — |
| Benicarolmesartan medoxomil | Olmesartan medoxomil 40 mg/1 | Tablet, Film coatedOral | 0713-0942 | 00713-0942-30 | — |
| Tazarotene | Tazarotene .5 mg/g | CreamTopical | 0713-0765 | 00713-0765-3100713-0765-60 | — |
| Ambienzolpidem tartrate | Zolpidem tartrate 5 mg/1 | Tablet, Film coatedOral | 0713-5401 | 00713-5401-01 | — |
| Ambienzolpidem tartrate | Zolpidem tartrate 10 mg/1 | Tablet, Film coatedOral | 0713-5421 | 00713-5421-01 | — |
| Ambien CRzolpidem tartrate | Zolpidem tartrate 6.25 mg/1 | Tablet, CoatedOral | 0713-5501 | 00713-5501-01 | — |
| Ambien CRzolpidem tartrate | Zolpidem tartrate 12.5 mg/1 | Tablet, CoatedOral | 0713-5521 | 00713-5521-01 | — |
| Ketoconazole | Ketoconazole 20 mg/mL | Shampoo, SuspensionTopical | 0713-0592 | 00713-0592-04 | — |
| MICONAZOLE 3 COMBINATION PACK (miconazole nitrate) kitmiconazole nitrate | — | Kit | 0713-0593 | 00713-0593-77 | — |
| Sucralfate | Sucralfate 1 g/10mL | SuspensionOral | 0713-0791 | 00713-0791-75 | — |
| calcipotriene and betamethasone dipropionate | Betamethasone dipropionate .5 mg/g; Calcipotriene 50 ug/g | SuspensionTopical | 0713-0848 | 00713-0848-6000713-0848-92 | — |
| Nitroglycerin | Nitroglycerin 4 mg/g | OintmentRectal | 0713-0564 | 00713-0564-31 | — |
| hydrocortisone and acetic acid | Acetic acid 20 mg/mL; Hydrocortisone 10 mg/mL | SolutionAuricular (Otic) | 0713-0849 | 00713-0849-09 | — |
| Docosanol | Docosanol 100 mg/g | CreamTopical | 0713-0353 | 00713-0353-0200713-0353-62 | — |
| Metronidazole | Metronidazole 7.5 mg/g | GelVaginal | 0713-0575 | 00713-0575-71 | — |
| Dapsone | Dapsone 50 mg/g | GelTopical | 0713-0886 | 00713-0886-1800713-0886-60 | — |
| Metronidazole | Metronidazole 10 mg/g | GelTopical | 0713-0574 | 00713-0574-60 | — |
| cevimeline hydrochloride | Cevimeline hydrochloride 30 mg/1 | CapsuleOral | 0713-0937 | 00713-0937-01 | — |
| Betaine | Betaine 1 g/g | Powder, For solutionOral | 0713-0352 | 00713-0352-81 | — |
| Fluocinonide | Fluocinonide .5 mg/g | CreamTopical | 0713-0663 | 00713-0663-1500713-0663-3100713-0663-60 | — |
| Griseofulvin | Griseofulvin 125 mg/5mL | SuspensionOral | 0713-0850 | 00713-0850-04 | — |
| Tazarotene | Tazarotene 1 mg/g | GelTopical | 0713-0804 | 00713-0804-3100713-0804-99 | — |
| Tazarotene | Tazarotene .5 mg/g | GelTopical | 0713-0805 | 00713-0805-3100713-0805-99 | — |
| Clomidclomiphene citrate | Clomiphene citrate 50 mg/1 | TabletOral | 0713-0885 | 00713-0885-0900713-0885-30 | — |
| Tribenzorolmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | Olmesartan medoxomil 40 mg/1 + 2 more ingredients | Tablet, Film coatedOral | 0713-0876 | 00713-0876-30 | — |
| Tribenzorolmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | Olmesartan medoxomil 40 mg/1 + 2 more ingredients | Tablet, Film coatedOral | 0713-0877 | 00713-0877-30 | — |
| Tribenzorolmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | Olmesartan medoxomil 40 mg/1 + 2 more ingredients | Tablet, Film coatedOral | 0713-0878 | 00713-0878-30 | — |
| Effientprasugrel hydrochloride | Prasugrel hydrochloride 10 mg/1 | Tablet, CoatedOral | 0713-0882 | 00713-0882-30 | — |
| Evoxaccevimeline hydrochloride | Cevimeline hydrochloride 30 mg/1 | CapsuleOral | 0713-0883 | 00713-0883-01 | — |
| Benicarolmesartan medoxomil | Olmesartan medoxomil 5 mg/1 | Tablet, Film coatedOral | 0713-0860 | 00713-0860-30 | — |
| Benicarolmesartan medoxomil | Olmesartan medoxomil 20 mg/1 | Tablet, Film coatedOral | 0713-0861 | 00713-0861-30 | — |
| Effientprasugrel hydrochloride | Prasugrel hydrochloride 5 mg/1 | Tablet, CoatedOral | 0713-0881 | 00713-0881-30 | — |
| Benicarolmesartan medoxomil | Olmesartan medoxomil 40 mg/1 | Tablet, Film coatedOral | 0713-0862 | 00713-0862-30 | — |
| Benicar HCTolmesartan medoxomil-hydrochlorothiazide | Olmesartan medoxomil 20 mg/1; Hydrochlorothiazide 12.5 mg/1 | Tablet, Film coatedOral | 0713-0863 | 00713-0863-30 | — |
| Benicar HCTolmesartan medoxomil-hydrochlorothiazide | Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 12.5 mg/1 | Tablet, Film coatedOral | 0713-0864 | 00713-0864-30 | — |
| Benicar HCTolmesartan medoxomil-hydrochlorothiazide | Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 25 mg/1 | Tablet, Film coatedOral | 0713-0865 | 00713-0865-30 | — |
| Azoramlodipine besylate and olmesartan medoxomil | Amlodipine besylate 5 mg/1; Olmesartan medoxomil 20 mg/1 | Tablet, Film coatedOral | 0713-0870 | 00713-0870-30 | — |
| Azoramlodipine besylate and olmesartan medoxomil | Amlodipine besylate 10 mg/1; Olmesartan medoxomil 20 mg/1 | Tablet, Film coatedOral | 0713-0871 | 00713-0871-30 | — |
| Azoramlodipine besylate and olmesartan medoxomil | Amlodipine besylate 5 mg/1; Olmesartan medoxomil 40 mg/1 | Tablet, Film coatedOral | 0713-0872 | 00713-0872-30 | — |
| Azoramlodipine besylate and olmesartan medoxomil | Amlodipine besylate 10 mg/1; Olmesartan medoxomil 40 mg/1 | Tablet, Film coatedOral | 0713-0873 | 00713-0873-30 | — |
| Tribenzorolmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | Olmesartan medoxomil 20 mg/1 + 2 more ingredients | Tablet, Film coatedOral | 0713-0874 | 00713-0874-30 | — |
| Tribenzorolmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | Olmesartan medoxomil 40 mg/1 + 2 more ingredients | Tablet, Film coatedOral | 0713-0875 | 00713-0875-30 | — |
Cosette Pharmaceuticals, Inc.: common questions
- What is Cosette Pharmaceuticals, Inc.'s NDC labeler code?
- 0713. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Cosette Pharmaceuticals, Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.